European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Chemical

Merck Completes Acquisition of Exelead and Plans to Invest More Than € 500 Million in Technology Scale-Up

by Marie Weil
February 24, 2022
A A
Share on LinkedinShare on Twitter

Merck today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash.

  • Continued investment in Exelead’s capabilities planned over the next ten years
  • Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
  • Company now offers comprehensive end-to-end services across mRNA value chain

Merck, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable Merck’s Life Science business sector to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. Merck plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.

“With the addition of Exelead’s leading capabilities and highly experienced team, Merck achieves an important milestone in becoming one of the leading CDMO players in mRNA vaccines and therapeutics, offering an integrated CDMO across the mRNA value chain from pre-clinical to commercial,” said Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science. “mRNA holds much promise as a treatment well beyond Covid-19 and we will further invest in this technology to help realize its potential.”

Exelead, a biopharmaceutical CDMO, specializes in PEGylated products and complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delivery technology, which is key in mRNA vaccines and therapeutics for use in Covid-19 and many other indications. The company has experience in all development phases from pre-clinical development to commercial contract manufacturing for LNP formulations, including fill and finish. Exelead will complement Merck’s more than 20 years’ experience in producing lipids as well as its mRNA manufacturing capabilities acquired through AmpTec in 2020. This integrated offering will accelerate Merck’s ability to bring life-enhancing vaccines and treatments to patients faster by simplifying supply chain complexity and enhancing speed to market through its end-to-end portfolio.

Over the past two years, Merck’s Life Science business sector has made significant investments to advance traditional and novel modalities (mAb, ADC, HP-API, viral vector, and mRNA) through acquisitions and expansions. The acquisition of Exelead is another milestone to accelerate innovation in Merck’s Process Solutions and Life Science Services businesses, one of the company’s three growth engines (“Big 3”), through targeted smaller to medium-sized acquisitions with high impact.

Tags: < Invest<< HIGHLIGHTS

Related Industries

Chemical

New Beiersdorf plant in Leipzig officially opened

September 23, 2023
Chemical

BASF launches first biomass balance plastic additives

September 20, 2023
Chemical

BASF is paving the way for an infinite range of sustainable plastic solutions at Fakuma 2023

September 20, 2023
Chemical

Amelia IRION appointed Vice President Human Resources for Air Liquide, effective September 18, 2023

September 8, 2023
Chemical

Bringing the power of Dow innovation to Labelexpo Europe 2023

September 6, 2023
Chemical

Henkel unveils its first world-class Battery Engineering Center in its Inspiration Center Duesseldorf

September 5, 2023

Siemens Healthineers presents mammography system with groundbreaking new imaging technology

September 28, 2023

...

Hyundai-Kia’s Head of Battery and H2 Fuel Cell Development Chang Hwan Kim Elected as President of FISITA from ’25-’27

September 14, 2023

...

Air Liquide takes a further step in developing the hydrogen sector in France

September 15, 2023

...

Menzies Aviation renews Jazeera Airways contract in Kuwait and wins new business in Europe and Pakistan

September 6, 2023

...

Talking not Typing: Continental and Google Cloud Equip Cars with Generative Artificial Intelligence IAA MOBILITY 2023

September 5, 2023

...

Kate Thomson appointed as bp interim chief financial officer

September 20, 2023

...

KKR Provides £75 million Financing Facility to TalkTalk

September 9, 2023

...

BT and Johnson Controls collaborate to help businesses reach Net Zero faster

September 14, 2023

...

ABB to invest $280 million in its European Robotics hub in Sweden

September 14, 2023

...

Huawei Ireland launches new 2023 STEM programme with global prize fund of $100K

September 13, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist